A Study of NeuroVax™, a Novel Therapeutic TCR Peptide Vaccine for Pediatric Multiple Sclerosis
Clinical trial NCT02200718 · UNKNOWN
Trial details
- NCT number
- NCT02200718
- Sponsor
- Immune Response BioPharma, Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-31
- Primary completion
- 2024-11-09
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.